Abstract Details
|
Rebecca G. Straus Farber, MD
(Columbia University Irving Medical Center)
PRESENTER |
Dr. Straus Farber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. |
| Amar Dhand, MD, DPhil | Dr. Dhand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ECHAS, LLC. Dr. Dhand has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ultress Quinn. The institution of Dr. Dhand has received research support from NIH. Dr. Dhand has received intellectual property interests from a discovery or technology relating to health care. |
| Seth N. Levin, MD (Biogen) | Dr. Levin has received personal compensation for serving as an employee of Biogen. Dr. Levin has received stock or an ownership interest from Biogen. |
| No disclosure on file | |
| No disclosure on file | |
| Victoria Leavitt, PhD, FAAN (Columbia University Irving Medical Center) | Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care. |